{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack

RxCUI: 754508
RxNorm name: {1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack
Display name: {1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack
Full name: {1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack
Term type: GPCK
Status: DailyMed mapping
Updated: 2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
APREPITANT	APREPITANT	Torrent Pharmaceuticals Limited	af9b6086-4bf2-472c-8740-4134eaaebace	2026-06-11	Warnings, Adverse reactions	Exact identifier rxcui: 754508
Aprepitant	APREPITANT	BluePoint Laboratories	a78aaa00-a46b-4f9e-a415-2fca9e9a4fb4	2026-03-27	Warnings, Adverse reactions	Exact identifier rxcui: 754508
APREPITANT	APREPITANT	Golden State Medical Supply, Inc.	377c3ecb-fdec-dde4-e063-6294a90a29bd	2026-03-09	Warnings, Adverse reactions	Exact identifier rxcui: 754508
Aprepitant	APREPITANT	Glenmark Pharmaceuticals Inc., USA	d72e0e10-4557-41b0-b65d-d395468cad19	2026-01-28	Warnings, Adverse reactions	Exact identifier rxcui: 754508
Aprepitant	APREPITANT	Sandoz Inc	f58b8944-93ee-4be1-a238-cc0061ddd93a	2024-09-09	Warnings, Adverse reactions	Exact identifier rxcui: 754508
EMEND	APREPITANT	Merck Sharp & Dohme LLC	696f9e80-9cae-403b-de9e-078343ce4713	2024-07-05	Warnings, Adverse reactions	Exact identifier rxcui: 754508

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 7 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
696f9e80-9cae-403b-de9e-078343ce4713	{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack [GPCK] · aprepitant 125 MG (1), 80 MG (2) Oral Capsule 3 Count Pack [PSN]	2	42	These highlights do not include all the information needed to use EMEND CAPSULES and EMEND FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EMEND CAPSULES and EMEND FOR ORAL SUSPENSION. EMEND (aprepitant) capsules, for oral use EMEND (aprepitant) for oral suspension Initial U.S. Approval: 2003	20240705
f58b8944-93ee-4be1-a238-cc0061ddd93a	{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack [GPCK] · aprepitant 125 MG (1), 80 MG (2) Oral Capsule 3 Count Pack [PSN]	2	15	These highlights do not include all the information needed to use APREPITANT CAPSULES safely and effectively. See full prescribing information for APREPITANT CAPSULES. APREPITANT capsules, for oral use Initial U.S. Approval: 2003	20240909
d72e0e10-4557-41b0-b65d-d395468cad19	{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack [GPCK] · aprepitant 125 MG (1), 80 MG (2) Oral Capsule 3 Count Pack [PSN]	2	13	These highlights do not include all the information needed to use APREPITANT CAPSULES safely and effectively. See full prescribing information for APREPITANT CAPSULES. APREPITANT capsules, for oral use Initial U.S. Approval: 2003	20260128
af9b6086-4bf2-472c-8740-4134eaaebace	{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack [GPCK] · aprepitant 125 MG (1), 80 MG (2) Oral Capsule 3 Count Pack [PSN]	2	8	These highlights do not include all the information needed to use APREPITANT CAPSULES safely and effectively. See full prescribing information for APREPITANT CAPSULES. APREPITANT capsules, for oral use Initial U.S. Approval:2003	20241002
377c3ecb-fdec-dde4-e063-6294a90a29bd	{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack [GPCK] · aprepitant 125 MG (1), 80 MG (2) Oral Capsule 3 Count Pack [PSN]	2	3	APREPITANT CAPSULES. These highlights do not include all the information needed to use APREPITANT CAPSULES safely and effectively. See full prescribing information for APREPITANT CAPSULES. APREPITANT capsules, for oral use Initial U.S. Approval:2003	20260309
db16d6b9-3b89-431d-97f9-9b4a8300e913	{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack [GPCK] · aprepitant 125 MG (1), 80 MG (2) Oral Capsule 3 Count Pack [PSN]	2	3	These highlights do not include all the information needed to use EMEND safely and effectively. See full prescribing information for EMEND. EMEND (aprepitant) Capsules Initial U.S. Approval: 2003	20100319
a78aaa00-a46b-4f9e-a415-2fca9e9a4fb4	{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack [GPCK] · aprepitant 125 MG (1), 80 MG (2) Oral Capsule 3 Count Pack [PSN]	2	2	These highlights do not include all the information needed to use APREPITANT CAPSULES safely and effectively. See full prescribing information for APREPITANT CAPSULES. APREPITANT capsules, for oral use Initial U.S. Approval: 2003	20260327